FGFR2 GENE REARRANGEMENT

Clinical trials for FGFR2 GENE REARRANGEMENT explained in plain language.

Never miss a new study

Get alerted when new FGFR2 GENE REARRANGEMENT trials appear

Sign up with your email to follow new studies for FGFR2 GENE REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat liver cancer

Disease control Recruiting now

This study is testing whether combining two drugs, pemigatinib and durvalumab, can help control a specific type of advanced bile duct cancer that has a particular genetic change (FGFR-2). It is for adults whose cancer has worsened after initial treatment. The main goal is to see …

Matched conditions: FGFR2 GENE REARRANGEMENT

Phase: PHASE2 • Sponsor: Mehmet Akce • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

FGFR2 GENE REARRANGEMENT

Get alerted when new FGFR2 GENE REARRANGEMENT trials appear

New hope for Tough-to-Treat liver cancer